Phase 3 Hematopoietic Stem Cell Transplant Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in AML/MDS Patients Aged > 50 Years: a Multicenter, Randomized, Phase 3 Trial
VenentoclaxALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONMyeloid Malignancies+3 more
First Affiliated Hospital of Zhejiang University186 enrolled18 locationsNCT07396480
Recruiting
Phase 3
Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT
ThrombocytopeniaHematopoietic Stem Cell Transplantation
First Affiliated Hospital of Zhejiang University404 enrolled1 locationNCT07442513
Recruiting
Phase 3
Haplo-cord HCT vs. Haplo-HCT for T-ALL Patients
Acute T Cell Lymphoblastic LeukemiaHaploidentical Hematopoietic Stem Cell TransplantationCord Blood
The First Affiliated Hospital of Soochow University146 enrolled1 locationNCT06381817
Recruiting
Phase 3
Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic HSCT
Hematopoietic Stem Cell TransplantationStomatitisLow-Level Light Therapy
Instituto Nacional de Cancer, Brazil84 enrolled2 locationsNCT06071637